steven halpern posts
Posted Jul 2nd 2009 11:30AM by Steven Halpern
Filed under: Major movement, International markets, Newsletters, NIKE, Inc'B' (NKE), DJIA, Stocks to Buy, Recession
"The conditions are in place for a 'Best Buy' opportunity," says Jim Stack, whose buy signal should receive special attention give the accuracy of his sells signals which side-stepped the bear market.
In addition, the money manager and editor of Investech Market Analyst is beginning to increase his equity positions, such as Nike (NYSE: NKE). He states, "With a portfolio of iconic brands, an identified growth strategy, recognized innovation, and sound financial footing, Nike fits the bill of being a great company."
"Very rarely do we have all these conditions in place – that's only occurred five times in the last 45 years. Historically, this means we should give the growing evidence of a new bull market every benefit of doubt.
Continue reading Step up to Nike (NKE): A 'great company'
Posted Jun 30th 2009 3:40PM by Steven Halpern
Filed under: Newsletters, SanDisk Corp (SNDK), Stocks to Buy
"For two years chips stocks have unequivocally stunk; the industry has been mired in a host of problems, including massive overcapacity and shrinking demand," says Toby Smith, adding, "But that's changing."
In his ChangeWave Investing, he suggests, "One recommendation in this sector is SanDisk (NASDAQ: SNDK), the leader in flash memory -- one of the strongest segments in semis today."
"For the second quarter in a row the semiconductor sector is showing major signs of momentum that are so good that the industry ranked at the top of the nearly 20 industries we track each quarter.
"The bottom line is that these results clearly indicate that it is time to be invested in the semis, and the best way to do this is with two short-term plays.
Continue reading Toby Smith: In the chips with Sandisk
Posted Jun 29th 2009 4:30PM by Steven Halpern
Filed under: Microsoft (MSFT), Newsletters, Stocks to Buy
"Microsoft Corporation (NASDAQ: MSFT), already a holding on our buy list, was added to Goldman Sachs' Conviction Buy List," says Bill Martin. In BullMarket.com, he offers the reasoning for his continued buy rating.
"Analyst Sarah Friar at Goldman recently raised her price target on the name to $29 from $25 saying, 'We are adding Microsoft to our Conviction List as we think the combination of better revenue drivers, improved expense management, and sizable cash balances provides more opportunities for bottom-line beats.'
"'Windows 7, Windows Server 2008 R2, Bing, Xbox 360 and new Halo content, Office 2010, and the Azure Cloud provide renewed innovation beyond anything we have seen in multiple years,' Friar wrote.
Continue reading Microsoft (MSFT): Bet on Bing?
Posted Jun 26th 2009 1:30PM by Steven Halpern
Filed under: Newsletters, Urban Outfitters (URBN), Stocks to Buy, Recession
"Stocks have struggled lately after their huge recovery; still, I continue to see opportunities, and I especially like Urban Outfitters (NASDAQ: URBN)," says Mark Skousen in The Turnaround Alert.
"Urban Outfitters, the apparel retailer, after it beat Wall Street analysts' estimates. Two years ago, the stock was selling for $37 a share.
"But today, it's selling for nearly half that. During the deep recession, retailers have seen sales drop as consumers cut back on spending for clothing and other discretionary purchases. As a result, retail apparel stocks fell sharply.
Continue reading Urban Outfitters (URBN): Dressed for success?
Posted Jun 25th 2009 11:00AM by Steven Halpern
Filed under: Newsletters, Abbott Laboratories (ABT), Teva Pharm Indus ADR (TEVA), S and P 500, DJIA, Stocks to Buy
"Stocks are likely in a new downtrend," says Michael Ashbaugh. In Marketwatch's The Technical Indicator, he looks at the S&P's prospects and some drug stocks set to buck the trend.
"The S&P 500 has violated its major moving averages in the closely tracked 900 area. The recent downturn was convincingly bearish, placing the burden on market bulls to reassert the uptrend.
"After finding resistance in the 923 area, the S&P sold off sharply, edging back under its 200-day moving average, which currently holds at 900 and now marks resistance. This is bearish price action.
Continue reading Tech talk from MarketWatch
Posted Jun 23rd 2009 1:30PM by Steven Halpern
"Most of the government 's proposed changes for the financial markets aren't new or needed; but what will happen will be a boost for some and a bane for others," says Neil George.
Long-known in the newsletter community for his expertise in income investing, the advisor has just launched a new blog service, Stocks that Pay You. Here, he looks at some winners and losers from the current proposals for financial regulation.
George says, "In my view, these supposedly massive changes amount to window dressing. Banks and other related firms can continue to do what they've always done: cherry pick regulators and play off one regulator against another.
"So, unless we get the government actually empowering the guys down the line inside all of these agencies and departments, don't look for any big changes, because - while the players and the names might be changing - the contest is staying the same.
Continue reading Income ideas: Winners from financial regulation
Posted Jun 22nd 2009 1:40PM by Steven Halpern
Filed under: Newsletters, Stocks to Buy
"Biotech company Celgene Corp. (NASDAQ: CELG) is a prime example of a stock that plays both offense and defense," says Ian Wyatt.
In his Top Stock Insights, he explains, "The valuation is low and growth is attractive. With the pipeline of products in development, Celegene offers investors a huge upside potential."
"Celgene offers investors a steady product base, a variety of drug treatments in development and a cash pile ready to purchase existing technologies.
"Celgene engages in the discovery of therapies designed to treat cancer and immune-inflammatory related diseases. They have a number of products at the commercial stage.
Continue reading Celgene (CELG): Play offense and defense with biotech
Posted Jun 18th 2009 10:30AM by Steven Halpern
Filed under: International markets, Newsletters, International Business Machines (IBM), DJIA, Stocks to Buy
"Overall, we believe quality technology stocks offer above-average growth potential and attractive valuations," says Gregory Dorsey.
In Stephen Leeb's The Complete Investor, he explains, "International Business Machines(NYSE: IBM) has plowed ahead despite a daunting economic and business environment; we are adding the stock to our Growth & Income Portfolio."
"For prudent investors in this challenging economy, most of the major technology companies are financially solid, often with little or no debt and lots of cash on their books. This makes them good long-term vehicles even if the economy remains off the rails for a prolonged period.
Continue reading IBM (IBM): Growth and value
Next Page >